Cancer Communications | Articles

Cancer Communications | Articles

Cancer Communications

Affiliated with

• 
• 
• Cancer Communications is affiliated with Chinese Anti-Cancer Association and US Chinese Anti-Cancer Association.

1. Original Article

   Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis

   Cancer cells reprogram metabolism for proliferation. Phosphoglycerate kinase 1 (PGK1), as a glycolytic enzyme and newly identified protein kinase, coordinates glycolysis and mitochondrial metabolism. However, ...

   Authors:Fei Shao, Xueying Yang, Wei Wang, Juhong Wang, Wei Guo, Xiaoli Feng, Susheng Shi, Qi Xue, Shugeng Gao, Yibo Gao, Zhimin Lu and Jie He

   Citation:Cancer Communications 2019 39:54

   Published on: 2 October 2019

   • ViewFull Text
    
   • ViewPDF
2. Content Type:Review

   Pathological transition as the arising mechanism for drug resistance in lung cancer

   Despite the tremendous efforts for improving therapeutics of lung cancer patients, its prognosis remains disappointing. This can be largely attributed to the lack of comprehensive understanding of drug resista...

   Authors:Yueqing Chen, Waiying Yvonne Tang, Xinyuan Tong and Hongbin Ji

   Citation:Cancer Communications 2019 39:53

   Published on: 1 October 2019

   • ViewFull Text
    
   • ViewPDF
3. Content Type:Research Highlight

   A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer

   Authors:Jian Ma and Burton B. Yang

   Citation:Cancer Communications 2019 39:52

   Published on: 1 October 2019

   • ViewFull Text
    
   • ViewPDF
4. Content Type:Letter To The Editor

   Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience

   Authors:Qian Zhao, Feng Li, Ping Song, Xiaogang Zhou, Zhiming An, Jiangang Mei, Jingjing Shao, Hanqing Li, Xuli Wang, Xing Guo and Yongping Zhai

   Citation:Cancer Communications 2019 39:51

   Published on: 27 September 2019

   • ViewFull Text
    
   • ViewPDF
5. Content Type:Correction

   Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis

   In the original publication of this article [1], the first affiliation name in the Author details section should be updated to ‘Department of Radiation Oncology, National Cancer Center/National Clinical Resear...

   Authors:Jun-Fang Liao, Qun Zhang, Xiao-Jing Du, Mei Lan, Shan Liu, Yun-Fei Xia, Xiu-Yu Cai and Wei Luo

   Citation:Cancer Communications 2019 39:50

   Published on: 23 September 2019

   The original article was published in Cancer Communications 2019 39:40

   • ViewFull Text
    
   • ViewPDF
6. Content Type:Original Article

   Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis

   The optimal number of retrieved lymph nodes (LNs) in gastric cancer (GC) is still debatable and previous studies proposing new classification alternatives mostly focused on the number of retrieved LNs without ...

   Authors:Siwei Pan, Pengliang Wang, Yanan Xing, Kai Li, Zhenning Wang, Huimian Xu and Zhi Zhu

   Citation:Cancer Communications 2019 39:49

   Published on: 13 September 2019

   • ViewFull Text
    
   • ViewPDF
7. Content Type:Review

   Cancer cell reprogramming: a promising therapy converting malignancy to benignity

   In the past decade, remarkable progress has been made in reprogramming terminally differentiated somatic cells and cancer cells into induced pluripotent cells and cancer cells with benign phenotypes. Recent st...

   Authors:Lanqi Gong, Qian Yan, Yu Zhang, Xiaona Fang, Beilei Liu and Xinyuan Guan

   Citation:Cancer Communications 2019 39:48

   Published on: 29 August 2019

   • ViewFull Text
    
   • ViewPDF
8. Content Type:Letter To The Editor

   Radiation pneumonitis complicated by Pneumocystis carinii in patients with thoracic neoplasia: a clinical analysis of 7 cases

   Authors:Zhixue Fu, Xu Yang, Nan Bi, Yirui Zhai, Dongfu Chen, Wenqing Wang, Lei Deng, Tao Zhang, Zongmei Zhou and Jun Liang

   Citation:Cancer Communications 2019 39:47

   Published on: 23 August 2019

   • ViewFull Text
    
   • ViewPDF
9. Content Type:Study Protocol

   Effects of two types of exercise training on psychological well-being, sleep, quality of life and physical fitness in patients with high-grade glioma (WHO III and IV): study protocol for a randomized controlled trial

   There is existing evidence on whether and to what degree regular exercise training improves the quality of life (QoL) among cancer survivors. However, in regards to patients with high-grade glioma (HGG; WHO gr...

   Authors:Dominik Cordier, Markus Gerber and Serge Brand

   Citation:Cancer Communications 2019 39:46

   Published on: 9 August 2019

   • ViewFull Text
    
   • ViewPDF
10. Content Type:Research Highlight

    Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France

    Authors:Haibo Qiu

    Citation:Cancer Communications 2019 39:45

    Published on: 8 August 2019

    • ViewFull Text
     
    • ViewPDF
11. Content Type:Letter To The Editor

    Clinical outcomes of angiosarcoma: a single institution experience

    Authors:Jae-Joon Kim, Seyoung Seo, Jeong Eun Kim, Sung-Ho Jung, Si Yeol Song and Jin-Hee Ahn

    Citation:Cancer Communications 2019 39:44

    Published on: 6 August 2019

    • ViewFull Text
     
    • ViewPDF
12. Content Type:Review

    Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives

    Lung cancer is the leading cause of cancer mortality worldwide. Dendritic cells (DCs) are the key factors providing protective immunity against lung tumors and clinical trials have proven that DC function is r...

    Authors:Jing-Bo Wang, Xue Huang and Fu-Rong Li

    Citation:Cancer Communications 2019 39:43

    Published on: 15 July 2019

    • ViewFull Text
     
    • ViewPDF
13. Content Type:Original Article

    Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China

    The prevalence of Lynch syndrome and screening strategies for this disorder in Chinese patients with endometrial cancer have seldom been investigated. Such data would be essential for the screening, prevention...

    Authors:Xiaopei Chao, Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong, Yalan Bi and Jinghe Lang

    Citation:Cancer Communications 2019 39:42

    Published on: 15 July 2019

    • ViewFull Text
     
    • ViewPDF
14. Content Type:Original Article

    Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells

    The interaction between CD137 and its ligand (CD137L) plays a major role in the regulation of immune functions and affects cancer immunotherapy. CD137 is a cell surface protein mainly located on activated T ce...

    Authors:Christophe Glorieux and Peng Huang

    Citation:Cancer Communications 2019 39:41

    Published on: 9 July 2019

    • ViewFull Text
     
    • ViewPDF
15. Content Type:Original Article

    Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis

    Promising efficacy and manageable toxicity of docetaxel-based concurrent chemoradiotherapy (CCRT) were reported in head and neck cancer. In addition, the effect of CCRT in combination with cisplatin and/or 5-f...

    Authors:Jun-Fang Liao, Qun Zhang, Xiao-Jing Du, Mei Lan, Shan Liu, Yun-Fei Xia, Xiu-Yu Cai and Wei Luo

    Citation:Cancer Communications 2019 39:40

    Published on: 27 June 2019

    The Correction to this article has been published in Cancer Communications 2019 39:50

    • ViewFull Text
     
    • ViewPDF
16. Content Type:Editorial

    Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma

    The standard of care for patients with locoregionally advanced nasopharyngeal carcinoma is concurrent platinum-based chemoradiotherapy. Existing literature have demonstrated that the addition of gemcitabine an...

    Authors:Yuan Zhang, Ying Sun and Jun Ma

    Citation:Cancer Communications 2019 39:39

    Published on: 25 June 2019

    • ViewFull Text
     
    • ViewPDF
17. Content Type:Original Article

    Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

    The JACOB trial (NCT01774786) was a double-blinded, placebo-controlled, randomized, multicenter, international, phase III trial evaluating the efficacy and safety of adding pertuzumab to trastuzumab and chemot...

    Authors:Tianshu Liu, Yanru Qin, Jin Li, Ruihua Xu, Jianming Xu, Shujun Yang, Shukui Qin, Yuxian Bai, Changping Wu, Yixiang Mao, Haiyan Wu, Yilin Ge and Lin Shen

    Citation:Cancer Communications 2019 39:38

    Published on: 24 June 2019

    • ViewFull Text
     
    • ViewPDF
18. Content Type:Letter To The Editor

    Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression

    Authors:Jie Wang, Jianzhong Xi, Hanshuo Zhang, Juan Li, Yuchao Xia, Ruibin Xi and Zhijun Xi

    Citation:Cancer Communications 2019 39:37

    Published on: 21 June 2019

    • ViewFull Text
     
    • ViewPDF
19. Content Type:Review

    China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy

    On May 8, 2018, the China National Medical Products Administration (NMPA) approved anlotinib, an orally administered anti-angiogenesis inhibitor, for the treatment of patients with advanced non-small cell lung...

    Authors:Ming Zhou, Xiaoyuan Chen, Hong Zhang, Lin Xia, Xin Tong, Limin Zou, Ruimin Hao, Jianhong Pan, Xiao Zhao, Dongmei Chen, Yuanyuan Song, Yueli Qi, Ling Tang, Zhifang Liu, Rong Gao, Yuankai Shi…

    Citation:Cancer Communications 2019 39:36

    Published on: 20 June 2019

    • ViewFull Text
     
    • ViewPDF
20. Content Type:Letter To The Editor

    Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer

    Authors:Romano Demicheli, Marco Fornili, Patrizia Querzoli, Massimo Pedriali, Saverio Alberti, Christine Desmedt and Elia Biganzoli

    Citation:Cancer Communications 2019 39:35

    Published on: 19 June 2019

    • ViewFull Text
     
    • ViewPDF
21. Content Type:Review

    Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells

    Cancer cell growth is associated with immune surveillance failure. Nowadays, restoring the desired immune response against cancer cells remains a major therapeutic strategy. Due to the recent advances in biolo...

    Authors:Jean-François Rossi, Patrice Céballos and Zhao-Yang Lu

    Citation:Cancer Communications 2019 39:34

    Published on: 14 June 2019

    • ViewFull Text
     
    • ViewPDF
22. Content Type:Letter To The Editor

    Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?

    Authors:Yaxiong Zhang, Lianpeng Chang, Wenfeng Fang, Yunpeng Yang, Lanjun Zhang, Shaodong Hong, Huaqiang Zhou, Yanfang Guan, Xin Yi and Li Zhang

    Citation:Cancer Communications 2019 39:33

    Published on: 13 June 2019

    • ViewFull Text
     
    • ViewPDF
23. Content Type:Original Article

    A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes

    The prognosis of gastric cancer patients with a limited number of pathologically examined lymph nodes (eLN, < 16) is dismal compared to those with adequately eLN (≥ 16), yet they are still classified within th...

    Authors:Sharvesh Raj Seeruttun, Lipu Xu, Fangwei Wang, Xiaodong Yi, Cheng Fang, Zhimin Liu, Wei Wang and Zhiwei Zhou

    Citation:Cancer Communications 2019 39:32

    Published on: 10 June 2019

    • ViewFull Text
     
    • ViewPDF
24. Content Type:Original Article

    Modelling the probability of erroneous negative lymph node staging in patients with colon cancer

    Patients in who with insufficient number of analysed lymph nodes (LNs) are more likely to receive an incorrect LN staging. The ability to calculate the overall probability of undiagnosed LN involvement errors ...

    Authors:Carlos Fortea-Sanchis, Erica Forcadell-Comes, David Martínez-Ramos and Javier Escrig-Sos

    Citation:Cancer Communications 2019 39:31

    Published on: 6 June 2019

    • ViewFull Text
     
    • ViewPDF
25. Content Type:Original Article

    PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer

    Programmed cell death ligand-1 (PD-L1) and ligand-2 (PD-L2) interaction with programmed cell death protein-1 (PD-1) represent an immune-inhibiting checkpoint mediating immune evasion and is, accordingly, an im...

    Authors:Trine Vilsbøll Larsen, Dianna Hussmann and Anders Lade Nielsen

    Citation:Cancer Communications 2019 39:30

    Published on: 3 June 2019

    • ViewFull Text
     
    • ViewPDF
26. Content Type:Original Article

    Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)

    A phase II clinical trial of the comparison between eribulin plus gemcitabine (EG) and paclitaxel plus gemcitabine (PG) as first-line chemotherapy for patients with metastatic breast cancer (MBC) found that th...

    Authors:Ji-Yeon Kim, Seri Park, Seock-Ah Im, Sung-Bae Kim, Joohyuk Sohn, Keun Seok Lee, Yee Soo Chae, Ki Hyeong Lee, Jee Hyun Kim, Young-Hyuck Im, Tae-Yong Kim, Kyung-Hun Lee, Jin-Hee Ahn, Gun Min Kim, In Hae Park, Soo Jung Lee…

    Citation:Cancer Communications 2019 39:29

    Published on: 28 May 2019

    • ViewFull Text
     
    • ViewPDF
27. Content Type:Original Article

    CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial

    The 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) regimen is the standard first-line treatment for metastatic colorectal cancer (mCRC), however, the optimal second-line regimen for KRAS wild-type mCRC patie...

    Authors:Yuankai Shi, Jin Li, Jianming Xu, Yan Sun, Liwei Wang, Ying Cheng, Wei Liu, Guoping Sun, Yigui Chen, Li Bai, Yiping Zhang, Xiaohui He, Yi Luo, Zhehai Wang, Yunpeng Liu, Qiang Yao…

    Citation:Cancer Communications 2019 39:28

    Published on: 24 May 2019

    • ViewFull Text
     
    • ViewPDF
28. Content Type:Letter To The Editor

    Is cancer-related death associated with circadian rhythm?

    Authors:Shing Fung Lee and Miguel Angel Luque-Fernandez

    Citation:Cancer Communications 2019 39:27

    Published on: 14 May 2019

    • ViewFull Text
     
    • ViewPDF
29. Content Type:Original Article

    The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

    Oxaliplatin, irinotecan, 5-fluorouracil, and l-leucovorin (FOLFIRINOX) has become one of the first-line treatment options for advanced pancreatic cancer (PC). However, the relatively high rate of grade 3 or 4 adv...

    Authors:Zhi-Qiang Wang, Fei Zhang, Ting Deng, Le Zhang, Fen Feng, Feng-Hua Wang, Wei Wang, De-Shen Wang, Hui-Yan Luo, Rui-Hua Xu, Yi Ba and Yu-Hong Li

    Citation:Cancer Communications 2019 39:26

    Published on: 8 May 2019

    • ViewFull Text
     
    • ViewPDF
30. Content Type:Original Article

    Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?

    In the post-Z0011 trial era, the need to perform surgical axillary staging for early-stage breast cancer patients, who are treated with breast-conserving therapy (BCT), is being questioned. We conducted a retr...

    Authors:Jin Wang, Hailin Tang, Xing Li, Cailu Song, Zhenchong Xiong, Xi Wang, Xiaoming Xie and Jun Tang

    Citation:Cancer Communications 2019 39:25

    Published on: 8 May 2019

    • ViewFull Text
     
    • ViewPDF
31. Content Type:Original Article

    National trend of gastric cancer mortality in China (2003–2015): a population-based study

    Gastric cancer mortality decreased substantially over the last decades in most countries worldwide. This study aimed to assess the most recent national trend of gastric cancer mortality and examine the dispari...

    Authors:Kun Gao and Jun Wu

    Citation:Cancer Communications 2019 39:24

    Published on: 2 May 2019

    • ViewFull Text
     
    • ViewPDF
32. Content Type:Original Article

    Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance

    Tumor hypoxia is associated with metastasis and resistance to chemotherapy and radiotherapy. Genes involved in oxygen-sensing are clinically relevant and have significant implications for prognosis. In this st...

    Authors:Wai Hoong Chang, Donall Forde and Alvina G. Lai

    Citation:Cancer Communications 2019 39:23

    Published on: 29 April 2019

    • ViewFull Text
     
    • ViewPDF
33. Content Type:Short Report

    Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

    Cancer is the leading cause of death in China and depicting the cancer pattern of China would provide basic knowhows on how to tackle it more effectively. In this study we have reviewed several reports of canc...

    Authors:Rui-Mei Feng, Yi-Nan Zong, Su-Mei Cao and Rui-Hua Xu

    Citation:Cancer Communications 2019 39:22

    Published on: 29 April 2019

    • ViewFull Text
     
    • ViewPDF
34. Content Type:Review

    Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer

    Tumor immune microenvironment is closely related to tumor initiation, prognosis, and response to immunotherapy. The immune landscapes, number of infiltrating immune cells, and the localization of lymphocytes i...

    Authors:Tong Wu, Xuan Wu, Hong-Yang Wang and Lei Chen

    Citation:Cancer Communications 2019 39:21

    Published on: 18 April 2019

    • ViewFull Text
     
    • ViewPDF
35. Content Type:Letter To The Editor

    Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer

    Authors:Jie Zhang, Chen Tian, Fang Lv, Jianfei Wang, Wenbo Han, Jun Nie, Ling Dai, Weiheng Hu, Xiaoling Chen, Xiangjuan Ma, Guangming Tian, Di Wu, Sen Han, Yang Wang, Jieran Long, Ziran Zhang…

    Citation:Cancer Communications 2019 39:20

    Published on: 18 April 2019

    • ViewFull Text
     
    • ViewPDF
36. Content Type:Original Article

    An improved ileal conduit surgery for bladder cancer with fewer complications

    Radical cystectomy and urinary diversion remains the standard surgical treatment for patients with muscle-invasive or high-risk or recurrent non-muscle-invasive bladder cancer. Although this approach prolongs ...

    Authors:Zhiyong Li, Zhuowei Liu, Kai Yao, Zike Qin, Hui Han, Yonghong Li, Pei Dong, Yunlin Ye, Yanjun Wang, Zhiming Wu, Zhiling Zhang and Fangjian Zhou

    Citation:Cancer Communications 2019 39:19

    Published on: 18 April 2019

    • ViewFull Text
     
    • ViewPDF
37. Content Type:Letter To The Editor

    Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma

    Authors:Dehuan Xie, Wanqin Cheng, Shaowen Lv, Rui Zhong, Lei Wang, Jiang Hu, Mingli Wang, Shaomin Huang, Yong Su and Yunfei Xia

    Citation:Cancer Communications 2019 39:18

    Published on: 15 April 2019

    • ViewFull Text
     
    • ViewPDF
38. Content Type:Original Article

    Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis

    Internal tandem duplications (ITD) within the juxtamembrane domain of FMS-like tyrosine kinase 3 (FLT3) represent a poor prognostic indicator in acute myeloid leukemia (AML). Therapeutic benefits of tyrosine k...

    Authors:Xin You, Weiye Jiang, Wenhua Lu, Hui Zhang, Tiantian Yu, Jingyu Tian, Shijun Wen, Guillermo Garcia-Manero, Peng Huang and Yumin Hu

    Citation:Cancer Communications 2019 39:17

    Published on: 4 April 2019

    • ViewFull Text
     
    • ViewPDF
39. Content Type:Original Article

    Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial

    The benefit of systemic treatments in esophageal squamous cell carcinoma (ESCC) which has progressed after chemotherapy is still uncertain and optimal regimens based on randomized trials have not yet been esta...

    Authors:Jing Huang, Binghe Xu, Ying Liu, Junxing Huang, Ping Lu, Yi Ba, Lin Wu, Yuxian Bai, Shu Zhang, Jifeng Feng, Ying Cheng, Jie Li, Lu Wen, Xianglin Yuan, Changwu Ma, Chunhong Hu…

    Citation:Cancer Communications 2019 39:16

    Published on: 2 April 2019

    • ViewFull Text
     
    • ViewPDF
40. Content Type:Letter To The Editor

    Primary intrathoracic liposarcoma: a clinical analysis of 31 cases

    Authors:Zhixue Fu, Kun Yang, Xu Yang, Shulan Chen, Wenqing Wang, Dongfu Chen, Jun Zhao, Zhishan Li, Qinfu Feng, Zongmei Zhou, Luhua Wang, Shugeng Gao and Jun Liang

    Citation:Cancer Communications 2019 39:15

    Published on: 2 April 2019

    • ViewFull Text
     
    • ViewPDF
41. Content Type:Original Article

    The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study

    Currently, the diagnosis and treatment of nasopharyngeal carcinoma (NPC) patients with residual cervical lymphadenopathy following radical radiotherapy with or without chemotherapy are challenging. We investig...

    Authors:Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, Lin-Quan Tang, Qiu-Yan Chen, Huan-Xin Lin, Yu-Jing Liang, Jin-Jie Yan, Chao Lin, Shan-Shan Guo, Li-Ting Liu, Yang Li, Hao-Jun Xie, Qing-Nan Tang, Hu Liang, Ling Guo…

    Citation:Cancer Communications 2019 39:14

    Published on: 29 March 2019

    • ViewFull Text
     
    • ViewPDF
42. Content Type:Review

    Mucinous colorectal adenocarcinoma: clinical pathology and treatment options

    Mucinous colorectal adenocarcinoma is a distinct subtype of colorectal cancer (CRC) characterized by the presence of abundant extracellular mucin which accounts for at least 50% of the tumor volume. Mucinous c...

    Authors:Cong Luo, Shuyi Cen, Guojun Ding and Wei Wu

    Citation:Cancer Communications 2019 39:13

    Published on: 29 March 2019

    • ViewFull Text
     
    • ViewPDF
43. Content Type:Review

    Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy

    Robust and clinically convenient biomarkers for cancer diagnosis, early detection, and prognosis have great potential to improve patient survival and are the key to precision medicine. The advent of next-gener...

    Authors:Chang Zeng, Emily Kunce Stroup, Zhou Zhang, Brian C.-H. Chiu and Wei Zhang

    Citation:Cancer Communications 2019 39:12

    Published on: 29 March 2019

    • ViewFull Text
     
    • ViewPDF
44. Content Type:Review

    Recent trends from the results of clinical trials on gastric cancer surgery

    The Japan Clinical Oncology Group has recently conducted large scale clinical trials with findings that have revealed pivotal strategies for the treatment of resectable gastric cancer surgery. These findings i...

    Authors:Takashi Kiyokawa and Takeo Fukagawa

    Citation:Cancer Communications 2019 39:11

    Published on: 27 March 2019

    • ViewFull Text
     
    • ViewPDF
45. Content Type:Guideline And Consensus

    The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

    China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment p...

    Authors:Feng-Hua Wang, Lin Shen, Jin Li, Zhi-Wei Zhou, Han Liang, Xiao-Tian Zhang, Lei Tang, Yan Xin, Jing Jin, Yu-Jing Zhang, Xiang-Lin Yuan, Tian-Shu Liu, Guo-Xin Li, Qi Wu, Hui-Mian Xu, Jia-Fu Ji…

    Citation:Cancer Communications 2019 39:10

    Published on: 18 March 2019

    • ViewFull Text
     
    • ViewPDF